Clare Market Investments’s Vertex Pharmaceuticals VRTX Stock Holding History

Clare Market Investments’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,490	Closed	-$600K	–	159
2024 Q4	$600K	Sell	1,490 -140	-9%	-$64.9K	0.14%	84
2024 Q3	$758K	Buy	+1,630	New	+$783K	0.2%	65
2022 Q4	–	Sell	-735	Closed	-$213K	–	144
2022 Q3	$213K	Buy	+735	New	+$211K	0.09%	119
2022 Q2	–	Sell	-1,375	Closed	-$359K	–	176
2022 Q1	$359K	Buy	+1,375	New	+$326K	0.11%	109
2020 Q4	–	Sell	-820	Closed	-$223K	–	134
2020 Q3	$223K	Sell	820 -630	-43%	-$174K	0.11%	99
2020 Q2	$421K	Buy	+1,450	New	+$393K	0.25%	53

Other funds holding VRTX

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Clare Market Investments's VRTX Position: Q1 2025 in Review

Clare Market Investments sold out of Vertex Pharmaceuticals (VRTX) in Q1 2025, closing a stake of 1,490 shares — an estimated $600K sold.

Clare Market Investments first reported a position in VRTX in Q2 2020 and held it in 6 quarters. The position peaked at $758K in Q3 2024. 1,613 funds tracked by Wall St. Rank hold VRTX as of Q1 2025.

Clare Market Investments reported no remaining Vertex Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
Clare Market Investments sold 1,490 Vertex Pharmaceuticals shares in Q1 2025, an estimated $600K.
Clare Market Investments first reported a position in Vertex Pharmaceuticals in Q2 2020 and held it in 6 quarters.
Clare Market Investments's Vertex Pharmaceuticals position peaked at $758K in Q3 2024.
1,613 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2025.

Based on Clare Market Investments's 13F filing for Q1 2025, filed 10 Apr 2025.